Chiaramonte, M G <br/><br/>
An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.  [electronic resource] 

 -  The Journal of clinical investigation  Sep 1999 
 - 777-85 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI7325  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3 Cells<br/>Animals<br/>Cytokines--biosynthesis<br/>Female<br/>Interleukin-13--antagonists & inhibitors<br/>Interleukin-4--deficiency<br/>Liver--metabolism<br/>Liver Cirrhosis, Experimental--prevention & control<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Procollagen--genetics<br/>RNA, Messenger--analysis<br/>Schistosomiasis mansoni--complications<br/>Th1 Cells--immunology<br/>Th2 Cells--immunology